The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

THURSDAY, Oct. 17, 2024 (HealthDay News) -- Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

Novo Nordisk's SOUL trial reveals a 14% reduction in major cardiovascular events with oral semaglutide in patients with type ...

FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is ...

Starting next year, insurance companies, including Highmark, will introduce stricter requirements for covering GLP-1 weight ...

Wegovy has quickly gained popularity as a highly effective weight loss medication, but it's not always accessible due to the ...

Novo Nordisk on Monday reported the oral version of its drug semaglutide reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes by 14% in a large Phase III trial.

Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...

The "takings clause" in the Fifth Amendment to the U.S. Constitution might keep the federal government from creating ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...